Sign in

CIK 0001785530 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Werewolf Therapeutics, Inc.

Sign in to watch
Ticker
HOWL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
823523180
Phone
617-952-0555
Business address
303 WYMAN STREET, SUITE 300, WALTHAM, MA, 02451
  1. 8-K Event Regulation FD disclosure
  2. 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
  3. 8-K Event Material agreement
  4. 8-K Event Results of operations
  5. 8-K Event Results of operations
  6. 10-K Report Annual Report
  7. 8-K Event Results of operations
  8. 8-K Event Other events
  9. 8-K Event Exit or restructuring costs · Executive or director change · Regulation FD disclosure
  10. 8-K Event Delisting notice
  11. 8-K Event Other events
  12. 8-K Event Results of operations
  13. 8-K Event Delisting notice
  14. 8-K Event Results of operations · Regulation FD disclosure
  15. 8-K Event Bylaws or fiscal year change · Shareholder vote results
  16. 8-K Event Delisting notice
  17. 8-K Event Results of operations · Regulation FD disclosure
  18. DEF 14A Proxy Proxy Statement
  19. 10-K Report Annual Report
  20. 8-K Event Results of operations

Page 1 of 4 · 62 filings